REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sansure Biotech Inc. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sansure Biotech Inc. Profile Updated: November 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Sansure Biotech Inc. focuses on the R&D, production and sales of diagnostic reagents and instruments. The company provides testing reagents, testing instruments, gene testing services and third-party medical testing services. The company was founded in 2008, headquartered in Changsha City, China.

Headquarters
No. 680, Lusong Road, High-tech Industrial Development Zone, Changsha City, Hunan Province
Changsha; Hunan; Postal Code: 410205

Contact Details: Purchase the Sansure Biotech Inc. report to view the information.

Website: http://www.sansure.com.cn

Basic Information
Total Employees:
Purchase the Sansure Biotech Inc. report to view the information.
Outstanding Shares:
Purchase the Sansure Biotech Inc. report to view the information.
Registered Capital:
Purchase the Sansure Biotech Inc. report to view the information.
Financial Auditors:
Purchase the Sansure Biotech Inc. report to view the information.
Incorporation Date:
April 23, 2008
Key Executives
Purchase this report to view the information.
SECRETARY
Ownership Details
Purchase this report to view the information.
32.29%
Purchase this report to view the information.
7.56%
Purchase this report to view the information.
6.32%
Purchase this report to view the information.
5.59%
Purchase this report to view the information.
1.68%
Subsidiaries
Beijing St. Well Medical Laboratory Co., Ltd.
100%
Changsha Shengwei Digital Biotechnology Co., Ltd.
100%
Changsha Sokoya Biotechnology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Sansure Biotech Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
63.24%▲
Total operating revenue
8.16%▲
Operating profit (EBIT)
-43.04%▼
Net Profit (Loss) for the Period
-45.37%▼
Total assets
3.17%▲
Total equity
-1.02%▼
Operating Profit Margin (ROS)
-37.7%▼
Net Profit Margin
-31.4%▼
Return on Equity (ROE)
-1.8%▼
Quick Ratio
0%
Cash Ratio
1.7%▲

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Aba Chemicals Corporation
 
Hunan Warrant Pharmaceutical Co.,Ltd
Aurisco Pharmaceutical Co.,Ltd.
 
Zhuhai Rundu Pharmaceutical Co., Ltd.
Guangyuyuan Chinese Herbal Medicine Co.,Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo